chartexchange

CADL
Candel Therapeutics, Inc. Common Stock
stockNASDAQ

Market OpenNov 19, 2026 9:39:35 AM EST
5.37USD+0.940%(+0.05)82,338
Pre-marketNov 19, 2026 9:21:30 AM EST
5.2839USD-0.679%(-0.0361)
4.6500Bid6.1300Ask1.4800Spread

CADL Financials

In Q3 FY 2026 (ended ), Candel Therapeutics, Inc. Common Stock (CADL) reported net income of −$21.87M, operating cash flow of −$23.12M, and assets of $211.11M (filed ).

Loading financial statements…